Latest KFF Health News Stories
KHN’s ‘What the Health?’: Becerra Urges Congress to Expand Medicare, Address Rx Prices
Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.
As Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will Do
In an interview for KHN’s “What the Health?” podcast, HHS Secretary Xavier Becerra says the administration is eager for Congress to make changes to Medicare that will provide more benefits and make more older adults eligible for the program. He also said a priority will be making permanent the enhanced premium subsidies for Affordable Care Act marketplace plans.
Teen Volunteers Get a Foot in the Door for Nursing Home Careers
A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.
California Takes a Nibble at Offering Food Stamps to Undocumented Immigrants
Food insecurity soared during the pandemic, including among unauthorized immigrants, who are not eligible for federally funded food stamps. California’s Democratic lawmakers want to expand the benefit to that population, but opponents cite the massive ongoing cost to the state.
Biden Is Caught in the Middle of Polarizing Abortion Politics
The president, one of the last of a disappearing group of politicians who sought moderate compromises on abortion policy, is frustrating supporters. They wanted faster changes in federal rules. But abortion opponents — including Catholic bishops— are also taking him to task.
Government Oversight of Covid Air Cleaners Leaves Gaping Holes
Thousands of schools have spent millions of federal covid relief dollars snapping up air cleaning technology that claims to inactivate covid-19. But the devices fall into a regulatory gap.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues
Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home
Your dutiful columnist tried to make use of a federal “transparency” rule to compare the prices of common medical procedures in two California health care systems. It was a futile exercise.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
Delta Variant Surges in Colorado as the Bands Play On
Mesa County is a breeding ground for the covid-19 delta variant, but few would guess with tens of thousands of people flocking to the state’s largest country music festival.
Most Inmates Have Had Their Covid Shots — But Their Guards Likely Haven’t
Hesitancy about the vaccines among prison staffers has led to a striking disparity: Inmates are better protected than corrections officials.
A Family Wellness Check: California Invests in Treating Parents and Children Together
The state will be the first to offer comprehensive counseling services to parents during pediatric visits as part of Medicaid.
California’s Highest Covid Infection Rates Shift to Rural Counties
As vaccination rates rise across the state, the overall numbers of covid cases and deaths have plunged. But health officials are still reporting nearly 1,000 new cases and more than two dozen deaths a day. So, where does covid continue to simmer in California? And why?
As Covid Vaccinations Slow, Parts of the US Remain Far Behind 70% Goal
Vermont and Massachusetts lead the nation, with more than 70% of adults having had at least one dose of a covid-19 vaccine. Southern states like Tennessee lag far behind.
Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
Rural Ambulance Services Are in Jeopardy as Volunteers Age and Expenses Mount
Experts say rural communities must find new models to keep emergency services afloat as more 911 calls go unanswered.
‘An Arm and a Leg’: Tips for Fighting Medical Bills from ProPublica’s Marshall Allen
Veteran health journalist Marshall Allen has been exposing health care grifters for years. Now he’s written a book about how to fight them. Host Dan Weissmann spoke with Allen about some of the best tips from “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
New Research Finds J&J Vaccine Has Muscle Against Covid’s Delta Variant
The data is reassuring to people who got this shot.
